Navigation Links
URAC Announces First Companies to Earn New Pharmacy Benefit and Drug Therapy Management Accreditations
Date:10/2/2007

WASHINGTON, Oct. 2 /PRNewswire-USNewswire/ -- URAC announced today that 10 organizations have successfully earned its Pharmacy Benefit Management Accreditation, the first voluntary accreditation developed for the industry. Four organizations have also earned URAC's new accreditation for Drug Therapy Management, a range of pharmacy management services designed to optimize therapeutic outcomes for individual consumers.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030501/URACLOGO )

Nearly 70 percent of Americans receive their prescription medications through pharmacy benefit management companies. URAC accreditation assures for consumers and purchasers that the organization is clinically focused and meets quality standards for consumer protection and empowerment. The Pharmacy Benefit Management Standards were developed by more than 30 members of a multi-disciplinary stakeholder committee over the course of more than a year. Initial standards underwent a public review and comment period, then field testing by a dozen pharmacy benefit management organizations representing 52 percent of the current lives covered under pharmacy benefit management programs across the nation.

The standards address organizational quality, customer service, communications, disclosure of pricing policies, pharmaceutical distribution, drug utilization management, and formulary/pharmacy and therapeutics committee.

URAC's Drug Therapy Management Accreditation standards, developed concurrently with the Pharmacy Benefit Management standards, are designed to help organizations drive appropriate therapeutic outcomes for consumers with a clear focus on patient safety, outcomes measurement and quality improvement. They address a broad range of functions, such as development of clinical policies using evidence-based medicine; patient communication regarding medication use; and promoting consume
'/>"/>

SOURCE URAC
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)..., COLLEGE PARK, MD. - A long history of terrori...s in Mumbai. The Global Terrorism Database (GTD), ...tional Consortium for the Study of Terrorism and R...00 terrorist attacks in India since 1970. Fataliti...eely available online. , The GTD is the most com...
(Date:12/2/2008)...ASHINGTON, Dec. 2 EIN N...te providing in-depth news on lung cancer. , ,...atients are finding out that information is one of..., Responding to the growing demand for accurate ...creening procedures and drugs to treat it, EIN New...
(Date:12/2/2008)..., , ROCKVILLE, Md., Dec. 2 /PRNewswire-USNe...ed sleep periods and increased supervision of work...ining environment, according to a new Institute of...are Research and Quality. , , The report i...ee that reviewed the relationship between resident...
(Date:12/2/2008)...OCHESTER, N.Y., Dec. 2 V...provider of quantitative imaging for clinical,tri...ceeds $27 million,compared to $14.7 million at th...se. The company calculates backlog as the amount r... contracts. The duration of the studies,included ...
Breaking Medicine News(10 mins):Health News:India terrorism by the numbers 2Health News:EIN News Introduces 'Lung Cancer News Today'; Website Offers Information on Risk Factors, Treatment, Drugs 2Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 2Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 3Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 4Health News:VirtualScopics Backlog Rises to a Record $27 Million 2Health News:VirtualScopics Backlog Rises to a Record $27 Million 3
...mount Americans spent on arthritis medications mor...ast-rising number of people// with the disease, in...h month and the inflation-adjusted cost per prescr...by a UCSF researcher. Results from a six-year stu...
...ebate on abortion is polarizing the US. Striking a...Spitzer has said that he would introduce// a bill ...week a conservative-dominated Supreme Court upheld...Ban Act, signed by President Bush in 2003. The ban...
...esponsibility and resources for public health and ...al councils rather than with the NHS, argues an ex...f Durham University says that partnerships between...HS would then become a true meeting of the two sid...
...tists at the Lundberg Laboratory for Cancer Resear...cademy in Sweden have discovered a //new hereditar...red that women possessing a certain hereditary def...k , almost twenty times, of contracting breast can...
Other Medicine News:Health News:Treatment Cost for Arthritis on the Rise: Study 2Health News:New York Governor to Introduce Bill to Strengthen Abortion Rights 2Health News:Local Councils Should Be Responsible for Tackling Health Inequalities 2Health News:Gene Behind Breast Cancer Found 2
(Date:12/2/2008)... -- Micromet, Inc. (Nasdaq: MITI ), a biopharmac...bodies for the treatment of cancer, inflammation a...s entered into an agreement expanding its Committe...e Capital Limited, a private investment group. Un...mmitted to provide up to $75 million of capital du...
(Date:12/1/2008)...as announced that an oral,presentation of prelim...al,trial of TG101348 in myeloproliferative diseas...n Society of Hematology (ASH) Meeting. , , ... Title: A Phase I Study of TG101348, ...K2-Selective Inhibitor, in Patients with, ...
(Date:12/1/2008)...-way switch that, if turned off, causes lymphatic ...lose their identity and become more like blood end...PRNewswire-USNewswire/ -- Scientists at St. Jude ...a certain differentiated cell type is so ready to ...expression of a gene called Prox1 to dissuade it...
(Date:12/1/2008)...cember 9 at 11:00 am ET to Discuss Phase 2 Study R...Calif., Dec. 1 Sunesis...rmaceutical company focused on the development and...oday announced new data from its studies of vorelo...ted during the 50th American Society of Hematology...
Breaking Medicine Technology:Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Trouble quitting 3F 3A A new Pitt Carnegie Mellon smoking study may reveal why 25790 1Trouble quitting 3F 3A A new Pitt Carnegie Mellon smoking study may reveal why 25790 2Scientists ID Pathway That Makes Antipsychotic Drugs Work 25788 1Scientists ID Pathway That Makes Antipsychotic Drugs Work 25788 2Satyam Launches Comprehensive Mobile Healthcare Program for Rural Indians 25785 1Satyam Launches Comprehensive Mobile Healthcare Program for Rural Indians 25785 2Satyam Launches Comprehensive Mobile Healthcare Program for Rural Indians 25785 3Satyam Launches Comprehensive Mobile Healthcare Program for Rural Indians 25785 4Satyam Launches Comprehensive Mobile Healthcare Program for Rural Indians 25785 5SIRIUS XM Radio Joins Stand Up To Cancer Campaign with Live Broadcast of Star Studded Just Stand Up Fundraising Event on September 5 25783 1SIRIUS XM Radio Joins Stand Up To Cancer Campaign with Live Broadcast of Star Studded Just Stand Up Fundraising Event on September 5 25783 2SIRIUS XM Radio Joins Stand Up To Cancer Campaign with Live Broadcast of Star Studded Just Stand Up Fundraising Event on September 5 25783 3SIRIUS XM Radio Joins Stand Up To Cancer Campaign with Live Broadcast of Star Studded Just Stand Up Fundraising Event on September 5 25783 4
...lt stem cells cultivated from patients, own blood ...tients whose lower,extremities are affected by per...China., SHENZHEN, China, July 02, 2007 /PRNewswire...ank" href=,"http://www.beikebiotech.com/">http://w...led by Dr. Yang Xiaofeng at its,collaborating hosp...
...ILADELPHIA, July 3, 2007-- – The appearance ...b (Tarceva) is,strongly associated with longer sur...o;s developer, OSI Pharmaceuticals, Inc. This is,n...th a survival,advantage with EGFR inhibitors &ndas...ximab, panitumumab and others designed to,block ov...
Other Medicine Technology:Beike Biotechnology Study Suggests Adult Stem Cells Show Promise,for Peripheral Vascular Disease 2Beike Biotechnology Study Suggests Adult Stem Cells Show Promise,for Peripheral Vascular Disease 3Skin Rash Actually Signifies Better Outcomes for Pancreatic and,Lung Cancer Patients 2Skin Rash Actually Signifies Better Outcomes for Pancreatic and,Lung Cancer Patients 3Skin Rash Actually Signifies Better Outcomes for Pancreatic and,Lung Cancer Patients 4
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),
Steroid-eluting, screw-in pacing lead
Tendril SDX is one of the world's thinnest, extendable/retractable pacing leads. Implantable with a 7 F introducer, the lead's reduced body diameter is designed to lower the incidence of venous obstr
Tendril DX active-fixation leads allows for lower thresholds initially and during the lead maturation phase.
Medicine Products: